Skip to main content
Premium Trial:

Request an Annual Quote

Burnham Chemical Genomics Center Lands $10M Gift

NEW YORK (GenomeWeb News) — The Burnham Institute for Medical Research has received a $10 million gift for its Center for Chemical Genomics from San Diego real estate developer Conrad Prebys, Burnham said yesterday.

The genomics center, which houses multidisciplinary studies focused on drug discovery technologies, will adopt the philanthropist's name and will be called the Conrad Prebys Center for Chemical Genomics.

The center is headquartered in La Jolla, Calif., but it plans to open another facility in Orlando, Fla. this spring. When both facilities are fully operational, the CPCCG will be capable of screening over two million chemical compounds per day.

Burnham President and CEO John Reed said in a statement that the donation will "enable us to advance discoveries farther and faster."

Burnham won a grant of around $100 million from the National Institutes of Health last September to establish a center of the Molecular Libraries Production Centers Network.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.